The impact of COVID-19 on the burden of cardiovascular diseases (CVD) during the early
pandemic remains unclear. COVID-19 has become one of the leading causes of global …

Abstract During the Coronavirus Disease 2019 (COVID-19) pandemic, the epidemiology of
heart failure significantly changed with reduced access to health system resources and a …

Aims The severity of myocardial tissue damage following ST-elevation myocardial infarction
(STEMI) strongly determines short-and long-term prognosis. This study explored the impact …

Background Age-standardised noncommunicable disease (NCD) mortality and the
proportion of the elderly population in Latvia are high, while public health and health care …

Background Excess mortality has been used to assess the overall health impact of COVID-
19 across countries. Democracies aim to build trust in government and enable checks and …

Background The global community has been affected by the coronavirus disease 2019
(COVID-19), which emerged in December 2019. Since then, many studies have been …

governments enforced lockdown measures. At the same time, healthcare systems rapidly
repurposed by redeploying resources and staff to tackle this unique challenge. These …

Introduction To reduce mortality in hospitalized patients with COVID‐19 and cardiovascular
disease (CVD), it is necessary to understand the relationship between patient's symptoms …

Background While coronavirus 2019 (COVID-19) deaths were generally underestimated in
many countries, Hong Kong may show a different trend of excess mortality due to stringent …

Sažetak In the year 2021, the universal definition and classification of heart failure (HF) was
published that defines HF as a clinical syndrome with symptoms and/or signs caused by a …